FDA Warns 17 Companies Over Unapproved Alzheimer’s Drugs By Sam | March 5, 2019 FDA Commissioner Scott Gottlieb announced agency action against 17 companies for selling unapproved Alzheimer’s treatments. Source: Drug GMP Report Posted in Drug GMP Report